First RSV vaccine approved in U.S. after decades of attempts

The U.S. approved the first vaccine for the respiratory syncytial virus (RSV) on Wednesday, shots to protect older adults against a respiratory virus that’s most notorious for attacking babies but endangers their grandparents, too.